World Post Reporter
SEE OTHER BRANDS

Your global issues news reporter

World Post Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Post Reporter.

Press releases published on June 2, 2025

Severe Weather in Egypt Sparks Emergency, Postpones Exams

Severe Weather in Egypt Sparks Emergency, Postpones Exams

(MENAFN) Intense and unexpected weather conditions hit Alexandria, a city in northern Egypt, on Saturday. The event featured powerful gusts, significant thunderstorms, and hail, leading city officials to announce an emergency status and postpone school …

Egypt, Qatar Push for Temporary Gaza Ceasefire

Egypt, Qatar Push for Temporary Gaza Ceasefire

(MENAFN) On Sunday, Egypt and Qatar voiced optimism about reaching a prompt accord on a 60-day interim pause in hostilities between Israel and Hamas. This initiative is intended to create the groundwork for a lasting cessation of conflict within the Gaza …

Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome

Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome

Press release – No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome Copenhagen, Denmark, June 2, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. …

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first and only FDA-approved interchangeable denosumab biosimilars available in US Improves access for patients …

“It Won’t Be China That Takes Control — It’ll Be Musk”: Enrique Abeyta Says Trump’s AI Order Hands Elon the Reins of America’s Machine Future

“It Won’t Be China That Takes Control — It’ll Be Musk”: Enrique Abeyta Says Trump’s AI Order Hands Elon the Reins of America’s Machine Future

WASHINGTON, June 01, 2025 (GLOBE NEWSWIRE) -- Most headlines worry about foreign AI dominance. But former hedge fund manager Enrique Abeyta sees a different threat rising from within. Abeyta explains in his recent briefing that with Elon Musk’s AI …

Biognosys stellt Spectronaut 20 und SpectroMine 5 vor und setzt damit neue Maßstäbe in der Immunopeptidomik

Biognosys stellt Spectronaut 20 und SpectroMine 5 vor und setzt damit neue Maßstäbe in der Immunopeptidomik

ZÜRICH und BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Biognosys, ein weltweit führender Anbieter von massenspektrometriebasierten Proteomiklösungen, gibt die Einführung von Spectronaut® 20 und SpectroMine™ 5 auf der ASMS 2025 Annual Conference bekannt, die …

Biognosys lanza Spectronaut 20 y SpectroMine 5, estableciendo un nuevo hito en la inmunopeptidómica

Biognosys lanza Spectronaut 20 y SpectroMine 5, estableciendo un nuevo hito en la inmunopeptidómica

ZÚRICH y BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Biognosys, líder mundial en soluciones de proteómica basadas en espectrometría de masas, ha anunciado el lanzamiento de Spectronaut® 20 y SpectroMine™ 5 en la convención anual ASMS de 2025, que tendrá …

Biognosys zet toon in immunopeptidomics met Spectronaut 20 en SpectroMine 5

Biognosys zet toon in immunopeptidomics met Spectronaut 20 en SpectroMine 5

ZURICH en BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Tijdens de ASMS 2025 Annual Conference, die van 1 tot 5 juni wordt gehouden in Baltimore, presenteert Biognosys, een internationale koploper in proteomica-oplossingen op basis van massaspectrometrie, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service